Junho Chung

2.5k total citations
99 papers, 1.8k citations indexed

About

Junho Chung is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Junho Chung has authored 99 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 49 papers in Radiology, Nuclear Medicine and Imaging and 28 papers in Oncology. Recurrent topics in Junho Chung's work include Monoclonal and Polyclonal Antibodies Research (46 papers), Glycosylation and Glycoproteins Research (16 papers) and Cell Adhesion Molecules Research (9 papers). Junho Chung is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (46 papers), Glycosylation and Glycoproteins Research (16 papers) and Cell Adhesion Molecules Research (9 papers). Junho Chung collaborates with scholars based in South Korea, United States and Ethiopia. Junho Chung's co-authors include Hyori Kim, Soohyun Kim, Sukmook Lee, Yong‐Sung Kim, Inhee Mook‐Jung, Jaewon Lee, Youngjin Cho, Joonoh Kim, Soobeom Lee and Sang Eun Lee and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Junho Chung

94 papers receiving 1.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Junho Chung 939 436 406 310 237 99 1.8k
Jean-Philippe Stéphan 1.3k 1.4× 306 0.7× 405 1.0× 343 1.1× 299 1.3× 36 2.2k
Patricia Chévez‐Barrios 737 0.8× 604 1.4× 582 1.4× 149 0.5× 296 1.2× 144 2.8k
Georges Vassaux 1.3k 1.4× 187 0.4× 426 1.0× 246 0.8× 325 1.4× 94 2.7k
Akiko Ishii‐Watabe 1.7k 1.8× 695 1.6× 396 1.0× 497 1.6× 137 0.6× 98 2.5k
Zhiliang Wang 537 0.6× 362 0.8× 285 0.7× 258 0.8× 217 0.9× 117 1.8k
Chun Jeih Ryu 1.1k 1.1× 233 0.5× 430 1.1× 337 1.1× 400 1.7× 78 1.9k
Cary D. Austin 1.1k 1.2× 374 0.9× 395 1.0× 555 1.8× 137 0.6× 38 2.6k
Yingnan Zhang 1.8k 1.9× 591 1.4× 318 0.8× 295 1.0× 103 0.4× 90 2.9k
Thomas A. Haas 1.4k 1.5× 365 0.8× 272 0.7× 492 1.6× 82 0.3× 43 3.2k
Ruo‐Pan Huang 1.9k 2.0× 411 0.9× 730 1.8× 535 1.7× 128 0.5× 79 3.0k

Countries citing papers authored by Junho Chung

Since Specialization
Citations

This map shows the geographic impact of Junho Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junho Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junho Chung more than expected).

Fields of papers citing papers by Junho Chung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junho Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junho Chung. The network helps show where Junho Chung may publish in the future.

Co-authorship network of co-authors of Junho Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Junho Chung. A scholar is included among the top collaborators of Junho Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junho Chung. Junho Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Ki Hyun, Ju Hwan Kim, Min Ju Kang, et al.. (2024). Improved safety of chimeric antigen receptor T cells indirectly targeting antigens via switchable adapters. Nature Communications. 15(1). 9917–9917. 9 indexed citations
2.
Kim, Hyori, Sang Ju Lee, Seung Jun Oh, et al.. (2024). Direct and Indirect Chimeric Antigen Receptor T-Cell Imaging with PET/MRI in a Tumor Xenograft Model. Radiology. 310(2). e231406–e231406.
3.
Kim, Soohyun, Daewon Lee, Seung Ah Lee, et al.. (2023). Laser-Assisted Recovery of On-Chip Phage Viral DNA for Phage Fluorescence Immunoassay Microchip. BioChip Journal. 17(4). 431–438. 5 indexed citations
4.
Chung, Junho, et al.. (2023). Polymeric immunoglobulin receptor (pIgR) in cancer. Journal of Cancer Research and Clinical Oncology. 149(19). 17683–17690. 9 indexed citations
5.
Yoon, Dok Hyun, Hyungwoo Cho, Jae‐Cheol Jo, et al.. (2023). A phase 1 study of AT101, a novel anti-CD19 CAR-T cell therapy targeting a membrane-proximal epitope of CD19, in patients with relapsed or refractory B cell non-Hodgkin lymphoma.. Journal of Clinical Oncology. 41(16_suppl). 7522–7522.
6.
Kim, Ki Hyun, et al.. (2022). Optimization of peripheral blood volume for in silico reconstitution of the human B‐cell receptor repertoire. FEBS Open Bio. 12(9). 1634–1643. 1 indexed citations
7.
Yu, Byeongjun, Dohyun Yoo, Ki Hyun Kim, et al.. (2022). Effective Combination Immunotherapy through Vessel Normalization Using a Cancer‐Targeting Antiangiogenic Peptide–Antibody Hybrid. Advanced Therapeutics. 5(4). 1 indexed citations
8.
Lee, Yonghee, Jongtak Jung, Chang Kyung Kang, et al.. (2021). Stereotypic neutralizing V H antibodies against SARS-CoV-2 spike protein receptor binding domain in patients with COVID-19 and healthy individuals. Science Translational Medicine. 13(578). 43 indexed citations
9.
Kim, Sujeong, Sujeong Kim, Hyo‐Jung Lee, et al.. (2021). Neutralization of Zika virus by E protein domain III-Specific human monoclonal antibody. Biochemical and Biophysical Research Communications. 545. 33–39. 9 indexed citations
10.
Yu, Byeongjun, Hyungjun Kim, Yonghyun Lee, et al.. (2019). A Hybrid Platform Based on a Bispecific Peptide–Antibody Complex for Targeted Cancer Therapy. Angewandte Chemie. 131(7). 2027–2032. 3 indexed citations
11.
Yu, Byeongjun, Hyungjun Kim, Yonghyun Lee, et al.. (2019). A Hybrid Platform Based on a Bispecific Peptide–Antibody Complex for Targeted Cancer Therapy. Angewandte Chemie International Edition. 58(7). 2005–2010. 10 indexed citations
12.
Kim, Hyungjun, Minsuk Choi, Soyoung Lee, et al.. (2018). Antibody-Assisted Delivery of a Peptide–Drug Conjugate for Targeted Cancer Therapy. Molecular Pharmaceutics. 16(1). 165–172. 16 indexed citations
13.
Jeong, Jong Cheol, Myung-Gyu Kim, Hee Jung Jeon, et al.. (2016). Desensitization Using Bortezomib and High-dose Immunoglobulin Increases Rate of Deceased Donor Kidney Transplantation. Medicine. 95(5). e2635–e2635. 33 indexed citations
14.
Kim, Hye‐In, Sangyeop Lee, Jung Hyun Park, et al.. (2015). Orientation and density control of bispecific anti-HER2 antibody on functionalized carbon nanotubes for amplifying effective binding reactivity to cancer cells. Nanoscale. 7(14). 6363–6373. 10 indexed citations
15.
Lee, Sukmook, Jae Hyeon Kim, Kyong Soo Park, et al.. (2008). Hydrogen Peroxide-Induced VCAM-1 Expression in Pancreatic Islets and β-Cells Through Extracellular Ca2+ Influx. Transplantation. 86(9). 1257–1266. 11 indexed citations
16.
Kim, Yun‐Gon, et al.. (2005). The identification of xenoantigenic nonhuman carbohydrates in membrane proteins from porcine kidney by using mass spectrometry and exoglycosidase. 한국생물공학회 학술대회. 842–842.
17.
Yi, Kye Sook, Junho Chung, Kwang‐Hyun Park, et al.. (2004). Expression System for Enhanced Green Fluorescence Protein Conjugated Recombinant Antibody Fragment. PubMed. 23(5). 279–286. 9 indexed citations
18.
19.
Chung, June-Key, Dong‐Soo Lee, Myung‐Chul Lee, et al.. (1992). Establishment of I-131, Tc-99m Labeling Methods to In-house Anti-CEA Antibodies and Evaluation of the Immunological Characteristics. The Korean Journal of Nuclear Medicine. 26(2). 346–354. 2 indexed citations
20.
Chung, Junho, et al.. (1990). Purification of Laminin from Human Placenta. Experimental & Molecular Medicine. 22(2). 129–135.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean-Philippe Stéphan Breakdown of academic impact, for papers by Patricia Chévez‐Barrios Breakdown of academic impact, for papers by Georges Vassaux Breakdown of academic impact, for papers by Akiko Ishii‐Watabe Breakdown of academic impact, for papers by Zhiliang Wang Breakdown of academic impact, for papers by Chun Jeih Ryu Breakdown of academic impact, for papers by Cary D. Austin Breakdown of academic impact, for papers by Yingnan Zhang Breakdown of academic impact, for papers by Thomas A. Haas Breakdown of academic impact, for papers by Ruo‐Pan Huang
Rankless by CCL
2026